Genetic markers for tracking treatment response in bowel cancer
Part of Cancer, Digestive system clinical trials.
This study looks at how certain genetic changes in tumor tissue might help doctors monitor how well treatment is working for colorectal or small intestinal cancer. By joining, you may help researchers find better ways to track the disease and guide future treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with cancer in the colon, rectum, or small intestine.
- Your cancer has not spread to other parts of the body such as the liver or lungs.
- You have not yet had surgery, chemotherapy, or immunotherapy for this cancer.
- You do not have a history of another type of cancer.
- Your doctor can access your complete medical records, including blood test results (like tumor markers).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how gene changes called methylation can help doctors track how well treatment is working for gastric cancer. If you are newly diagnosed and have not had surgery or chemotherapy yet, you may be able to join.
This study tests whether a simple blood test can track how well your colorectal cancer is responding to first-line chemotherapy. By monitoring cancer markers in your blood, doctors may be able to detect treatment changes earlier than traditional imaging.
This trial uses a blood test to track genetic changes in esophageal cancer over time. It aims to see if these changes can show how well treatment is working.
This trial checks a blood test for “ctDNA methylation” to see who may be at higher risk of colorectal cancer returning after surgery. It may help doctors better judge whether adjuvant chemotherapy is working or needed.
This study is testing a new way to detect colorectal cancer early by looking for specific changes (gene methylation) in stool and blood samples. If you are 40 or older and have a colonoscopy scheduled, this non-invasive approach might help find cancer sooner.
This study is testing whether a blood test that looks for tiny bits of tumor DNA (ctDNA methylation) can help monitor how well treatment is working in people with colorectal cancer that has spread. If you are getting radiation and chemotherapy (with or without an immunotherapy drug), this trial may help your doctor see if the treatment is working sooner.
Hear when a new Intestinal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.